Publication | Closed Access

The A-to-Z Trial: Methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapy

ThrombosisCardiovascular DiseaseMedicineClinical TrialsCardiovascular PharmacologyHemostasisA-to-z TrialPharmacotherapySingle Trial InvestigatingCoagulopathyPlatelet AntagonistPharmacologyAnticoagulantHeparinsLow-molecular-weight Heparin